Mid-cap biotech companies increase revenues to $26.5 billion
09 April, 2015Research and consulting firm GlobalData has released a report comparing the competitive positions of 35 mid-cap biotechnology companies, finding an increase in combined total revenues from $24.8 billion in 2013 to $26.5 billion in 2014.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
Why is there no generic insulin?
23 March, 2015Researchers from Johns Hopkins University have delved into the history of the diabetes drug insulin in the hope of understanding why a generic version has never been made available in the US.
BioMeter shows re-emergence of late-stage biotech deals
28 October, 2014Law firm Morrison & Foerster (MoFo) has released its Q3 edition of BioMeter. The quarterly report measures the health of the biotech industry.
There are no free rides to the future: Australia's Chief Scientist
14 August, 2014 by Ian Chubb, Office of the Chief ScientistThis is a transcript of the 2014 Jack Beale Lecture on the Global Environment, hosted at the University of New South Wales.
Big pharma pays more upfront than SMEs
04 August, 2014Academics from Trinity College Dublin have shed light on the market dynamics and potential in licensing deals with big pharmaceutical companies. Their findings are of particular relevance to those working in and funding drug development worldwide.
Cosmetics consumers going cruelty-free
30 July, 2014Market research company Roy Morgan Research has found that consumers are making the shift towards cruelty-free beauty products. The findings align with the news that the Australian Labor Party is currently consulting with the public on the possibility of phasing out the importation, manufacture, sale and advertising of cosmetics or cosmetic ingredients tested on animals.
Advanced manufacturing heading overseas, says survey
16 June, 2014AusBiotech has released the results of the Biotechnology Industry Position Survey (2014). The survey finds that advanced manufacturing associated with the biotech industry is following traditional manufacturing and heading overseas.
How do Australians engage with science?
29 May, 2014 by Lauren DavisA national survey on Australians' engagement with science has found that the majority have extremely positive attitudes about science and technology, though they're not always clear about the details.
US excipients market forecast to rise
28 April, 2014US research firm The Freedonia Group has released the report 'Excipients', an industry study showcasing trends and forecasts in the pharmaceutical excipients market. The study also analyses market environment factors, evaluates company market share and profiles 47 US industry competitors.
E-commerce in the lab
09 April, 2014 by Karl Wyzenbeek, Managing Director, LabFriendConsumers in Australia have adopted the web as the go-to resource to find the best price on products from around the world. But while we shop online for ourselves looking for a bargain, are we doing this in the laboratory?
NHMRC research measures up, says report
12 February, 2014The National Health and Medical Research Council (NHMRC) has released Measuring Up 2013 - a report which analyses and compares the publication output of NHMRC health and medical research funding with other Australian research.
IChemE's top 10 chemically engineered inventions
07 February, 2014The Institution of Chemical Engineers (IChemE) has released the results of its survey on the most important chemically engineered inventions and solutions of the modern era. The top 10 list, comprising the inventions considered to have made the biggest impact on society, was voted for by IChemE's MediaEnvoys.
New website to chronicle Australians' engagement in science
03 February, 2014From today, Australian communication researchers will be able to monitor more closely what science Australians are being exposed to, with the launch of a new website chronicling science engagement activities across the country.
Continuous glucose monitoring market report released
20 December, 2013Allied Market Research (AMR) has released a market research report analysing current and future trends in the continuous glucose monitoring (CGM) market from 2012 to 2020. The report projects that the CGM market will reach $568.5 million by 2020 from its 2012 value of $194.8 million.
